questionText: To ask the Secretary of State for Health and Social Care, what assessment has been made of the proportion of terminated NICE health technology appraisals that are for blood cancer treatments compared to other cancers.
answerText: Since August 2019, 31% of National Institute for Health and Care Excellence (NICE) technology appraisals for blood cancer treatments were terminated as the company withdrew from the NICE appraisal process. For the same period, 21% of appraisals for all ca...
heading: Blood Cancer: Medical Treatments